A. Kantemirov

3-Bromofascaplysin is a prospective chemical compound for developing new chemotherapy agents in glioblastoma treatment.

M. Zhidkov, H. Sharma, Aruna Sharma, 2020, International review of neurobiology.

Buckwheat Grass Tea Beverages: Row Materials, Production Methods, and Biological Activity

Yury Prikhodko, A. Kantemirov, Tatiana Tanashkina, 2021, Food Processing: Techniques and Technology.

Study of Structure–Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents

M. A. Sidorova, V. Prassolov, C. Bokemeyer, 2022, Marine drugs.

Cytotoxic Marine Alkaloid 3,10-Dibromofascaplysin Induces Apoptosis and Synergizes with Cytarabine Resulting in Leukemia Cell Death

V. Prassolov, T. Lebedev, E. Vagapova, 2021, Marine drugs.

Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their Analogues

M. Zhidkov, S. Ermakova, S. Dyshlovoy, 2019, Marine drugs.

Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro

M. Zhidkov, I. Kudryavtsev, Y. Khotimchenko, 2018, Bulletin of Experimental Biology and Medicine.

A New Mild Method for Synthesis of Marine Alkaloid Fascaplysin and Its Therapeutically Promising Derivatives

V. Prassolov, M. Zhidkov, P. Spirin, 2023, Marine Drugs.

Syntheses of the marine alkaloids 6-oxofascaplysin, fascaplysin and their derivatives

A. Kuzmich, M. Zhidkov, A. N. Andin, 2018 .